Author:
Ghukasyan L. G.,Krasnov G. S.,Muravenko O. V.,Ikonnikova A. Y.,Yurasov R. A.,Baidun L. V.,Ibragimova S. Z.,Nasedkina T. V.
Subject
Structural Biology,Biophysics
Reference32 articles.
1. Schoch C., Kern W., Schnittger S., Büchner T., Hiddemann W., Haferlach T. 2004. The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroups. Haematologica. 89 (9), 108–290.
2. Jourdan E., Boissel N., Chevret S., Delabesse E., Renneville A., Cornillet P., Blanchet O., Cayuela J.M., Recher C., Raffoux E., Delaunay J., Pigneux A., Bulabois C.E., Berthon C., Pautas C., et al. 2013. Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia. Blood. 121 (12), 2213–2223.
3. Le Beau M.M., Larson R.A., Bitter M.A., Vardiman J.W., Golomb H.M., Rowley J.D. 1983. Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic clinicopathological association. N. Engl. J. Med. 309 (11), 630–636.
4. Döhner H., Estey E.H., Amadori S., Appelbaum F.R., Büchner T., Burnett A.K., Dombret H., Fenaux P., Grimwade D., Larson R.A., Lo-Coco F., Naoe T., Niederwieser D., Ossenkoppele G.J., Sanz M.A., et al. 2010. Diagnosis and management of acute myeloid leukemia in adults: Recommendations from an international expert panel, on behalf of the European Leukemia Net. Blood.115 (3), 453–474.
5. Sander A., Zimmermann M., Dworzak M., Fleischhack G., von Neuhoff C., Reinhardt D., Kaspers G.J., Creutzig U. 2010. Consequent and intensified relapse therapy improved survival in pediatric AML: Results of relapse treatment in 379 patients of three consecutive AML-BFM trials. Leukemia. 24, 1422–1428.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献